Sartorius reduces revenue by €26M to refund Trump tariffs to customers
Sartorius reduces revenue by €26M to refund Trump tariffs to customers.
Sartorius Stedim Biotech (Euronext Paris: DIM) is a leading international partner of the biopharmaceutical industry, providing integrated solutions for the entire bioprocess chain. Offers bioreactors, filtration, fluid management, and cell line technologies to biopharma manufacturers globally.
Company Info
Recent News
Sartorius reduces revenue by €26M to refund Trump tariffs to customers.
Leadership Team
Careers & Job Openings